The Liver Disease Panel includes LiverPRO—a certified algorithm developed by the health tech company Evido—requiring only age and routine blood markers for the timely detection of liver fibrosis With ...

Labcorp OnDemand enables convenient testing with the NASHnext® test, within a physician-directed care pathway to support identification of ...

Chronic liver disease poses a growing global health burden, driven in large part by metabolic risk factors and viral hepatitis. Fibrosis stage is the principal ...

Non-invasive biomarkers and scoring systems demonstrated effectiveness in differentiating chronic liver disease (CLD) from cirrhosis; non-invasive fibrosis scores such as the Lok index, King's score, ...

Non-invasive indicators of liver fibrosis could help with risk stratification for heart failure. The median follow-up duration was 10.7 years. For all three measures of liver fibrosis, the risk for ...

"[We] have conducted a large individual participant data meta-analysis and shown that screening strategies using sequential application of simple NITs like FIB-4 or NFS followed by LSM-VCTE achieve ...

ECU Health Medical Center has completed its first procedure using a new non-invasive technology designed to treat liver tumors, expanding access to advanced care in eastern North Carolina. Dr. Carlos ...